UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regulatory considerations on endpoints in ovarian cancer drug development

Cancer, 2017-07, Vol.123 (14), p.2604-2608

2017

Volltextzugriff (PDF)

US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic Assessments

Journal of clinical oncology, 2018-04, Vol.36 (12), p.1225-1231

2018

Volltextzugriff (PDF)

Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis

Oncoimmunology, 2020-01, Vol.9 (1), p.1748982

2020

Volltextzugriff (PDF)

L‐asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer

Journal of cellular and molecular medicine, 2012-10, Vol.16 (10), p.2369-2378

2012

Volltextzugriff (PDF)

FDA analysis of enrollment of older adults in clinical trials for cancer drug registration: A 10-year experience by the U.S. Food and Drug Administration

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.10009-10009

2017

Volltextzugriff (PDF)

Diagnosing leptomeningeal carcinomatosis with negative CSF cytology in advanced prostate cancer

Journal of clinical oncology, 2008-07, Vol.26 (19), p.3281-3284

2008

Volltextzugriff (PDF)

Setting the Record Straight on FDA Approvals in Oncology

JAMA internal medicine, 2017-08, Vol.177 (8), p.1222

2017

Volltextzugriff (PDF)

FDA analysis of patients with baseline autoimmune diseases treated with PD-1/PD-L1 immunotherapy agents

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3018-3018

2017

Volltextzugriff (PDF)

FDA analysis of patient enrollment by region in clinical trials for approved oncological indications

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2539-2539

2017

Volltextzugriff (PDF)

Tumor progression versus bone scan “flare” in new lesions detected on early bone scans in patients with chemo-naïve metastatic castration resistant prostate cancer (mCRPC) treated with placebo or enzalutamide

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.305-305

2016

Volltextzugriff (PDF)

FDA analysis of treatment beyond disease progression disease (PD) in patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab vs. everolimus

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4508-4508

2016

Volltextzugriff (PDF)

Association of clinical benefit rate (CBR) with survival: A pooled-analysis of metastatic breast cancer (MBC) trials submitted to the U.S. Food and Drug Administration (FDA)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e18091-e18091

2016

Volltextzugriff (PDF)

A U.S. Food and Drug Administration (FDA) pooled analysis of outcomes for bone only metastatic breast cancer (MBC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.570-570

2016

Volltextzugriff (PDF)

FDA subset analysis of the safety of nivolumab in elderly patients with advanced cancers

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.10010-10010

2016

Volltextzugriff (PDF)

Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome

Cancer, 2012-03, Vol.118 (6), p.1543-1553

2012

Volltextzugriff (PDF)

Remote Monitoring and Data Collection for Decentralized Clinical Trials

JAMA network open, 2024-04, Vol.7 (4), p.e246228

2024

Volltextzugriff (PDF)

Proteomic Profiling in Ovarian Cancer

International journal of gynecological cancer, 2009-12, Vol.19 (11 Suppl 2), p.S2-S6

2009

Volltextzugriff (PDF)

An ambulatory stabilisation program for children with newly diagnosed type 1 diabetes

Medical journal of Australia, 2004-03, Vol.180 (6), p.277-280

2004

Volltextzugriff (PDF)

First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

The New England journal of medicine, 2020-11, Vol.383 (21), p.2018-2029

2020

Volltextzugriff (PDF)

Primary Rewards and Aversive Outcomes Have Comparable Effects on Attentional Bias

Behavioral neuroscience, 2023-04, Vol.137 (2), p.89-94

2023

Volltextzugriff (PDF)

Relativistic kinematics of a magnetic soliton

Science (American Association for the Advancement of Science), 2020-12, Vol.370 (6523), p.1438-1442

2020

Volltextzugriff (PDF)

Chemogenetic Activation of Lateral Habenula Accelerates the Extinction of the Appetitive Conditioned Responses

Behavioral neuroscience, 2023-04, Vol.137 (2), p.95-100

2023

Volltextzugriff (PDF)

Artificial Muscles from Fishing Line and Sewing Thread

Science (American Association for the Advancement of Science), 2014-02, Vol.343 (6173), p.868-872

2014

Volltextzugriff (PDF)

Global Stroke Statistics 2019

International Journal of Stroke, 2020-10, Vol.15 (8), p.819-838

2020

Volltextzugriff (PDF)

Nutrient-sensing nuclear receptors PPAR[alpha] and FXR control liver energy balance

The Journal of clinical investigation, 2017-04, Vol.127 (4), p.1193

2017

Volltextzugriff (PDF)

1 – 25 von 618

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(602)
Mit Volltextzugriff
(503)

Publikationsform

Sprache

Englisch
(618)
Japanisch
(66)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Regulatory considerations on endpoints in ovarian cancer drug development

US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic Assessments

Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis

L‐asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer

FDA analysis of enrollment of older adults in clinical trials for cancer drug registration: A 10-year experience by the U.S. Food and Drug Administration

Diagnosing leptomeningeal carcinomatosis with negative CSF cytology in advanced prostate cancer

Setting the Record Straight on FDA Approvals in Oncology

FDA analysis of patients with baseline autoimmune diseases treated with PD-1/PD-L1 immunotherapy agents

FDA analysis of patient enrollment by region in clinical trials for approved oncological indications

Tumor progression versus bone scan “flare” in new lesions detected on early bone scans in patients with chemo-naïve metastatic castration resistant prostate cancer (mCRPC) treated with placebo or enzalutamide

FDA analysis of treatment beyond disease progression disease (PD) in patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab vs. everolimus

Association of clinical benefit rate (CBR) with survival: A pooled-analysis of metastatic breast cancer (MBC) trials submitted to the U.S. Food and Drug Administration (FDA)

A U.S. Food and Drug Administration (FDA) pooled analysis of outcomes for bone only metastatic breast cancer (MBC)

FDA subset analysis of the safety of nivolumab in elderly patients with advanced cancers

Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome

Remote Monitoring and Data Collection for Decentralized Clinical Trials

Proteomic Profiling in Ovarian Cancer

An ambulatory stabilisation program for children with newly diagnosed type 1 diabetes

First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

Primary Rewards and Aversive Outcomes Have Comparable Effects on Attentional Bias

Relativistic kinematics of a magnetic soliton

Chemogenetic Activation of Lateral Habenula Accelerates the Extinction of the Appetitive Conditioned Responses

Artificial Muscles from Fishing Line and Sewing Thread

Global Stroke Statistics 2019

Nutrient-sensing nuclear receptors PPAR[alpha] and FXR control liver energy balance

Aktive Filter

Suchergebnisse filtern